These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32871493)

  • 41. Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: A prospective observational study.
    Mitlid-Mork B; Bowe S; Gran JM; Bolstad N; Berg JP; Redman CW; Staff AC; Sugulle M
    PLoS One; 2020; 15(10):e0240473. PubMed ID: 33079955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The sFlt-1/PlGF ratio values within the <38, 38-85 and >85 brackets as compared to perinatal outcomes.
    Bednarek-Jędrzejek M; Kwiatkowski S; Ksel-Hryciów J; Tousty P; Nurek K; Kwiatkowska E; Cymbaluk-Płoska A; Torbé A
    J Perinat Med; 2019 Sep; 47(7):732-740. PubMed ID: 31339858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
    Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
    Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereological analysis of terminal villi, intervillous space and fibrinoid of adolescent placentas and birth weight of newborns.
    Marković S; Cerovac A; Kunosić S; Ramić S; Bećirović E
    Med Glas (Zenica); 2020 Feb; 17(1):145-150. PubMed ID: 31527558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia.
    Weel IC; Baergen RN; Romão-Veiga M; Borges VT; Ribeiro VR; Witkin SS; Bannwart-Castro C; Peraçoli JC; De Oliveira L; Peraçoli MT
    PLoS One; 2016; 11(6):e0157584. PubMed ID: 27315098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic analysis in placentas from sickle cell disease patients reveals a hypermethylation profile.
    Gil GP; Ananina G; Maschietto M; Lima SCS; da Silva Costa SM; Baptista LC; Ito MT; Costa FF; Costa ML; de Melo MB
    PLoS One; 2022; 17(9):e0274762. PubMed ID: 36129958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
    Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
    Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morphological and ultrastructural changes in the placenta of the diabetic pregnant Egyptian women.
    Abdelhalim NY; Shehata MH; Gadallah HN; Sayed WM; Othman AA
    Acta Histochem; 2018 Jul; 120(5):490-503. PubMed ID: 29871770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
    Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
    Hypertens Pregnancy; 2009 Feb; 28(1):95-108. PubMed ID: 19165674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analytical validation of soluble fms-like tyrosine and placental growth factor assays on B·R·A·H·M·S KRYPTOR Compact Plus automated immunoassay platform.
    Chan SL; Rana S; Chinthala S; Salahuddin S; Yeo KJ
    Pregnancy Hypertens; 2018 Jan; 11():66-70. PubMed ID: 29523276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD).
    Patel N; Sundaram N; Yang M; Madigan C; Kalra VK; Malik P
    J Biol Chem; 2010 May; 285(22):16713-22. PubMed ID: 20351105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsia.
    Suresh S; Mueller A; Salahuddin S; Naseem H; Dhir R; Rana S
    Pregnancy Hypertens; 2020 Jul; 21():124-131. PubMed ID: 32505096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.
    Shinohara S; Uchida Y; Kasai M; Sunami R
    Hypertens Pregnancy; 2017 Aug; 36(3):269-275. PubMed ID: 28737473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiogenesis biomarkers for the prediction of severe adverse outcomes in late-preterm preeclampsia.
    Villalain C; Herraiz I; Cantero B; Quezada S; Lopez A; Simón E; Galindo A
    Pregnancy Hypertens; 2020 Jan; 19():74-80. PubMed ID: 31927324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
    Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of the PI3K-Akt pathway suppresses sFlt1 expression in human placental hypoxia models in vitro.
    Park JK; Jeong JW; Kang MY; Baek JC; Shin JK; Lee SA; Choi WS; Lee JH; Paik WY
    Placenta; 2010 Jul; 31(7):621-9. PubMed ID: 20488538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiogenic factors for the prediction of preeclampsia in high-risk women.
    Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE
    Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.